Importance of CD4+CD25+ly in UC1. Investigation of Difference Between Blood Concentration IL 17, IL 33, Regulatory T ly in Patients With UC and Control Group
1 other identifier
observational
32
1 country
1
Brief Summary
Mucosal inflammation in patients with UC is the result of immunosuppression disturbance because decreasing number of regulatory T ly and activation IL 17
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2008
CompletedFirst Submitted
Initial submission to the registry
December 8, 2008
CompletedFirst Posted
Study publicly available on registry
December 9, 2008
CompletedDecember 9, 2008
December 1, 2008
December 8, 2008
December 8, 2008
Conditions
Study Arms (2)
2
control group
patients with UC
patients with UC, without corticosteroid or immunosuppressive therapy
Eligibility Criteria
patients with UC and control group
You may qualify if:
- endoscopic confirmed diagnosis
You may not qualify if:
- corticosteroid or immunosuppressive therapy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Klinički bolnički centar Split
Split, Croatia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 8, 2008
First Posted
December 9, 2008
Study Start
September 1, 2008
Last Updated
December 9, 2008
Record last verified: 2008-12